#France #Sébastien Huron #Ceva Animal Health #Marc Prikazsky #Libourne

Ceva Animal Health Appoints New Deputy CEO

Ceva Animal Health, recognized as one of the world's leading animal health companies and the fifth largest globally, has recently announced a significant leadership change with the appointment of Sébastien Huron as Deputy Chief Executive Officer (CEO). Effective immediately, Huron's appointment is part of a strategic governance evolution at Ceva, which aims to enhance its operational focus and accelerate its growth in a competitive landscape.

The decision was driven by the desire to implement a dual leadership structure, with current CEO Marc Prikazsky transitioning to the role of Executive Chairman. In this capacity, Prikazsky will concentrate on long-term strategic priorities and bolster the company's esteemed relationships with investors, while Huron will take charge of day-to-day operations and lead the Executive Committee.

Strengthening Governance and Strategic Vision

Marc Prikazsky expressed confidence in this evolution of governance, emphasizing the need for a clear focus on both strategic initiatives and operational excellence within the company. He stated, "This governance evolution reflects the scale Ceva has reached and our ambition to reinforce both strategic focus and operational excellence. I am delighted to welcome Sébastien, whose experience, global outlook, and deeply human leadership will be key assets."

Huron's extensive background in the animal health industry is expected to play a vital role as Ceva navigates its next phase of development. As a veterinarian trained at the National Veterinary School of Toulouse, Huron started his professional journey in the 1990s. He has accumulated over three decades of valuable experience in various leadership roles across multiple continents, enhancing his understanding of strategy, marketing, R&D, and industrial operations.

A Proven Leader with Global Expertise

Before joining Ceva, Huron held significant positions at several prominent companies in the animal health sector. His initial experience began at Mars Inc. in France, where he worked in marketing for the pet food division. He subsequently transitioned to Brazil to join Roussel-Uclaf and was deeply involved in the marketing and business development sectors. Notably, he also served as CEO of Virbac from 2017 to 2024, where he successfully led the company through a period marked by impressive organic growth.

In reflecting on his new role at Ceva, Huron conveyed his enthusiasm, stating, "I am honored to join Ceva at a moment when the company has an exceptional strategic foundation and a strong culture of innovation. I have always admired the entrepreneurial spirit and passion of Ceva's teams. My priority will be to support them with energy, experience, and an entrepreneurial mindset so that, together, we can accelerate the Group's development and continue to deliver meaningful value for our customers and partners worldwide."

Ceva’s Commitment to Innovation and Animal Health

As a company founded on the principles of innovation and excellence in animal health, Ceva is committed to providing a broad portfolio that includes preventive medicines, vaccines, and welfare products for various animals. With over 7,200 employees present in 47 countries, Ceva continues to strive for its vision of being a leader in animal health, encapsulated in its mantra, "Together, beyond animal health."

With Huron's leadership, the team at Ceva is poised to tackle major global challenges regarding animal health and welfare. It marks an exciting time for the company as it seeks to not only maintain its standing in the industry but also redefine its approach to meeting the needs of its customers and the animals that benefit from its products and services.

Conclusion

The appointment of Sébastien Huron as Deputy CEO signifies Ceva Animal Health's commitment to robust leadership during an important phase of growth. With a focus on operational management and innovative practices, Ceva aims to enhance its impact within the global animal health market, ensuring that it continues to contribute positively to the industry and society at large.